135 related articles for article (PubMed ID: 29611642)
1. The effect of budesonide on the expression of Ki-67 and PCNA and the apoptotic index in dogs with inflammatory bowel disease.
Szweda M; Rychlik A; Nowicki M; Kaczmar E
Pol J Vet Sci; 2017 Dec; 20(4):743-750. PubMed ID: 29611642
[TBL] [Abstract][Full Text] [Related]
2. Clinical, endoscopic and histopathological evaluation of the efficacy of budesonide in the treatment of inflammatory bowel disease in dogs.
Rychlik A; Kołodziejska-Sawerska A; Nowicki M; Szweda M
Pol J Vet Sci; 2016; 19(1):159-64. PubMed ID: 27096800
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of budesonide and prednisone for the treatment of idiopathic inflammatory bowel disease in dogs.
Dye TL; Diehl KJ; Wheeler SL; Westfall DS
J Vet Intern Med; 2013; 27(6):1385-91. PubMed ID: 24112400
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations and therapeutic effects of budesonide in dogs with inflammatory bowel disease.
Pietra M; Fracassi F; Diana A; Gazzotti T; Bettini G; Peli A; Morini M; Pagliuca G; Roncada P
Am J Vet Res; 2013 Jan; 74(1):78-83. PubMed ID: 23270349
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
[TBL] [Abstract][Full Text] [Related]
6. Effects of probiotic bacteria on mucosal polyamines levels in dogs with IBD and colonic polyps: a preliminary study.
Rossi G; Cerquetella M; Scarpona S; Pengo G; Fettucciari K; Bassotti G; Jergens AE; Suchodolski JS
Benef Microbes; 2018 Feb; 9(2):247-255. PubMed ID: 29022381
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing Intestinal Lymphoma From Inflammatory Bowel Disease in Canine Duodenal Endoscopic Biopsy Samples.
Carrasco V; Rodríguez-Bertos A; Rodríguez-Franco F; Wise AG; Maes R; Mullaney T; Kiupel M
Vet Pathol; 2015 Jul; 52(4):668-75. PubMed ID: 25487412
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of disease activity for canine inflammatory bowel disease.
Jergens AE
J Am Anim Hosp Assoc; 2004; 40(6):437-45. PubMed ID: 15533963
[TBL] [Abstract][Full Text] [Related]
9. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.
Luckschander N; Allenspach K; Hall J; Seibold F; Gröne A; Doherr MG; Gaschen F
J Vet Intern Med; 2006; 20(2):221-7. PubMed ID: 16594575
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
11. A scoring index for disease activity in canine inflammatory bowel disease.
Jergens AE; Schreiner CA; Frank DE; Niyo Y; Ahrens FE; Eckersall PD; Benson TJ; Evans R
J Vet Intern Med; 2003; 17(3):291-7. PubMed ID: 12774968
[TBL] [Abstract][Full Text] [Related]
12. Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease.
Maeda S; Ohno K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Nakajima M; Fujino Y; Tsujimoto H
J Vet Intern Med; 2013; 27(1):47-55. PubMed ID: 23216572
[TBL] [Abstract][Full Text] [Related]
13. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease.
Rossi G; Pengo G; Caldin M; Palumbo Piccionello A; Steiner JM; Cohen ND; Jergens AE; Suchodolski JS
PLoS One; 2014; 9(4):e94699. PubMed ID: 24722235
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease.
Dandrieux JR; Bornand VF; Doherr MG; Kano R; Zurbriggen A; Burgener IA
Am J Vet Res; 2008 Oct; 69(10):1279-85. PubMed ID: 18828683
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic and proliferation indexes in canine lymphoma.
Phillips BS; Kass PH; Naydan DK; Winthrop MD; Griffey SM; Madewell BR
J Vet Diagn Invest; 2000 Mar; 12(2):111-7. PubMed ID: 10730938
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial on the efficacy of masitinib in canine IBD.
Procoli F
Vet Rec; 2010 Nov; 167(19):760. PubMed ID: 21257519
[No Abstract] [Full Text] [Related]
19. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
Jergens AE; Crandell J; Morrison JA; Deitz K; Pressel M; Ackermann M; Suchodolski JS; Steiner JM; Evans R
J Vet Intern Med; 2010; 24(2):269-77. PubMed ID: 20051005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
